China Regenerative Medicine International Limited reported earnings results for the third quarter and nine months ended September 30, 2021. For the third quarter, the company reported sales was HKD 84.67 million compared to HKD 58.54 million a year ago. Net income was HKD 3.5 million compared to net loss of HKD 18.34 million a year ago. Basic earnings per share was HKD 0.00122 compared to basic loss per share of HKD 0.00974 a year ago. For the nine months, sales was HKD 199.98 million compared to HKD 107.85 million a year ago. Net income was HKD 19.73 million compared to net loss of HKD 182.07 million a year ago. Basic earnings per share was HKD 0.00691 compared to basic loss per share of HKD 0.13676 a year ago.